Vanda Pharmaceuticals Netherlands B.V.

Sleep Disorders

Clinical research in insomnia disorder with a focus on sleep outcomes, sleep maintenance, and symptom relief in pediatric and other affected populations.

  • Tasimelteon
  • Sleep outcomes
  • Pediatric insomnia

Interest in measuring changes in nightly sleep patterns and patient-reported sleep experience across multiple active research sites.

Depressive Disorders

Research activity in major depressive disorder, centered on depressive symptom burden and treatment response in patients receiving background antidepressant therapy.

  • MADRS Total Score
  • Adjunctive treatment
  • Antidepressant therapy

Work in this area reflects a therapeutic interest in additional options for persistent depressive symptoms and mood stabilization.

Neuropsychiatry

The sponsor’s trial portfolio spans conditions at the intersection of psychiatry and neurology, with attention to disorders affecting mood and sleep regulation.

  • Psychiatric symptoms
  • Sleep-wake regulation
  • Treatment response

Clinical interest extends to therapies that address functional impairment linked to disrupted sleep and depressive illness.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants

    Recruiting

    3 1
    Bulgaria Czechia Poland
  • Study of tasimelteon compared to placebo for treating insomnia in children

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland